New! Sign up for our free email newsletter.
Science News
from research organizations

Killer hospital bacteria: Cracking a superbug's armour

Date:
June 7, 2012
Source:
University of Alberta
Summary:
There's new hope for development of an antibiotic that can put down a lethal bacteria or superbug linked to the deaths of hundreds of hospital patients around the world. Researchers found a chink in the molecular armor of the pathogen Acinetobacter baumannii. The bacteria first appeared in the 1970s and in the last decade it developed a resistance to most antibiotics.
Share:
FULL STORY

There's new hope for development of an antibiotic that can put down a lethal "superbug" bacteria linked to the deaths of hundreds of hospital patients around the world, including a recent case at Edmonton's Royal Alexandra Hospital.

Researchers from the University of Alberta-based Alberta Glycomics Centre found a chink in the molecular armour of the pathogen Acinetobacter baumannii. The bacteria first appeared in the 1970s and in the last decade it has developed a resistance to most antibiotics.

U of A microbiologist Mario Feldman identified a mechanism that allows Acinetobacter baumannii to cover its surface with molecules known as glycoproteins. That led the researchers to another discovery. "If the superbug cannot produce glycoproteins they become less virulent and less capable of forming biofilms," said Feldman. "The biofilm protects the bacteria from antibiotics."

Acinetobacter baumannii is a particularly insidious and contagious pathogenic bacteria that has plagued hospitals around the world. It spreads from one person to another by physical contact. The bacteria can live on hard surfaces for several days and can cling to hospital equipment like catheter tubes and inhalers. Acinetobacter infection is also spread by coughing and sneezing.

Hospital patients whose immune systems are already worn down are the most susceptible to the bacteria. It infects wounds and can spread to the lungs, blood and brain.

The researchers say more work is required to understand how the bacteria produce glycoproteins. "We're hopeful our work will enable future development of drugs to interrupt the production of glycoproteins to weaken or eliminate the bacteria's shield against antibiotics," said Feldman.

Feldman is a principal investigator for the Alberta Glycomics Centre at the U of A. The list of coauthors includes U of A graduate students Jeremy Iwashkiw and Brent Weber, and research colleagues in Ottawa, Austria and Australia. Their work was published June 7 in the journal PLoS Pathogens.


Story Source:

Materials provided by University of Alberta. Original written by Brian Murphy. Note: Content may be edited for style and length.


Journal Reference:

  1. Jeremy A. Iwashkiw, Andrea Seper, Brent S. Weber, Nichollas E. Scott, Evgeny Vinogradov, Chad Stratilo, Bela Reiz, Stuart J. Cordwell, Randy Whittal, Stefan Schild, Mario F. Feldman. Identification of a General O-linked Protein Glycosylation System in Acinetobacter baumannii and Its Role in Virulence and Biofilm Formation. PLoS Pathogens, 2012; 8 (6): e1002758 DOI: 10.1371/journal.ppat.1002758

Cite This Page:

University of Alberta. "Killer hospital bacteria: Cracking a superbug's armour." ScienceDaily. ScienceDaily, 7 June 2012. <www.sciencedaily.com/releases/2012/06/120607180058.htm>.
University of Alberta. (2012, June 7). Killer hospital bacteria: Cracking a superbug's armour. ScienceDaily. Retrieved March 28, 2024 from www.sciencedaily.com/releases/2012/06/120607180058.htm
University of Alberta. "Killer hospital bacteria: Cracking a superbug's armour." ScienceDaily. www.sciencedaily.com/releases/2012/06/120607180058.htm (accessed March 28, 2024).

Explore More

from ScienceDaily

RELATED STORIES